NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Kotak Mahindra Mutual Fund Increases Stake in Park Medi World

Kotak Mahindra Mutual Fund has acquired an additional 1,75,164 equity shares of Park Medi World, increasing its holding in the company to above 5%. Prior to the latest purchase, the fund held 2,15,91,213 shares, representing 4.9988% of the company's total ownership and voting capital, as of March 13.

The acquisition was made through an open market transaction, with the additional shares accounting for 0.0405% of the company's share capital. This brings the fund's total holding in Park Medi World to above 5%, as per the company's statement.

Park Medi World has been a focus of interest for investors, with Nuvama, a brokerage firm, initiating coverage on the company with a 'buy' rating. The firm cited strong growth prospects for the North India-focused hospital network, driven by a gradual rebalancing of payer mixes toward higher-yielding private and self-pay segments, as well as supportive CGHS rate revisions of 25-30% effective October 2025.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

The company's stock opened lower at Rs 192.20 on the NSE on Monday, compared with the previous close of Rs 192.55. Shares of Park Medi World were trading at Rs 185.15 apiece on the NSE at around 3:15 pm, down 3.85%.

Key Figures:

  • Kotak Mahindra Mutual Fund stake in Park Medi World: above 5%
  • Number of additional shares acquired: 1,75,164
  • Previous stake in Park Medi World: 4.9988%
  • Target price of Nuvama: Rs 280
  • CGHS rate revisions: 25-30% effective October 2025

Investor Takeaway

Investors may consider Park Medi World as a potential buy opportunity due to its strong growth prospects.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.